Increased risk of arterial thromboembolic events after Staphylococcus aureus bacteremia: A matched cohort study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Increased risk of arterial thromboembolic events after Staphylococcus aureus bacteremia : A matched cohort study. / Mejer, N; Gotland, N; Uhre, M L; Westh, H; Schønheyder, H C; Petersen, A; Jensen, A G; Larsen, A R; Skov, R; Benfield, T; Danish Staphylococcal Bacteremia Study Group.
I: Journal of Infection, Bind 71, Nr. 2, 08.2015, s. 167-78.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Increased risk of arterial thromboembolic events after Staphylococcus aureus bacteremia
T2 - A matched cohort study
AU - Mejer, N
AU - Gotland, N
AU - Uhre, M L
AU - Westh, H
AU - Schønheyder, H C
AU - Petersen, A
AU - Jensen, A G
AU - Larsen, A R
AU - Skov, R
AU - Benfield, T
AU - Danish Staphylococcal Bacteremia Study Group
N1 - Copyright © 2015 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
PY - 2015/8
Y1 - 2015/8
N2 - OBJECTIVES: An association between infection and arterial thromboembolic events (ATE) has been suggested. Here we examined the risk of myocardial infarction (MI), stroke and other ATE after Staphylococcus aureus bacteremia (SAB).METHODS: Danish register-based nation-wide observational cohort study between 1995 and 2008 with matched control subjects from the general population.RESULTS: Within a year, 278 of 15,669 SAB patients and 2570 of 156,690 controls developed MI, stroke or another ATE. The incidence rates among SAB patients were highest within the first 30 days and decreased over a year. The adjusted relative risk of MI, stroke and other ATE during the first 30 days after SAB in patients compared to controls were 2.2 (95% CI: 1.6-3.1), 5.5 (95% CI: 3.8-8.3) and 15.5 (95% CI: 6.9-35), respectively. Compared to controls, the increased adjusted relative risk persisted for 30 days for MI, 180 days for stroke and one year for other ATE. Increasing age, hypertension, atrial flutter/fibrillation, prior ATE and endocarditis in SAB patients were associated with an increased risk of ATE.CONCLUSIONS: SAB was associated with a short-term increased risk of ATE that persisted longer dependent on type of event. Studies are warranted to investigate treatment strategies to diminish ATE after SAB.
AB - OBJECTIVES: An association between infection and arterial thromboembolic events (ATE) has been suggested. Here we examined the risk of myocardial infarction (MI), stroke and other ATE after Staphylococcus aureus bacteremia (SAB).METHODS: Danish register-based nation-wide observational cohort study between 1995 and 2008 with matched control subjects from the general population.RESULTS: Within a year, 278 of 15,669 SAB patients and 2570 of 156,690 controls developed MI, stroke or another ATE. The incidence rates among SAB patients were highest within the first 30 days and decreased over a year. The adjusted relative risk of MI, stroke and other ATE during the first 30 days after SAB in patients compared to controls were 2.2 (95% CI: 1.6-3.1), 5.5 (95% CI: 3.8-8.3) and 15.5 (95% CI: 6.9-35), respectively. Compared to controls, the increased adjusted relative risk persisted for 30 days for MI, 180 days for stroke and one year for other ATE. Increasing age, hypertension, atrial flutter/fibrillation, prior ATE and endocarditis in SAB patients were associated with an increased risk of ATE.CONCLUSIONS: SAB was associated with a short-term increased risk of ATE that persisted longer dependent on type of event. Studies are warranted to investigate treatment strategies to diminish ATE after SAB.
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Bacteremia
KW - Cohort Studies
KW - Denmark
KW - Female
KW - Humans
KW - Incidence
KW - Male
KW - Middle Aged
KW - Myocardial Infarction
KW - Risk Assessment
KW - Staphylococcal Infections
KW - Stroke
KW - Thromboembolism
KW - Time Factors
KW - Young Adult
U2 - 10.1016/j.jinf.2015.03.010
DO - 10.1016/j.jinf.2015.03.010
M3 - Journal article
C2 - 25936743
VL - 71
SP - 167
EP - 178
JO - Journal of Infection
JF - Journal of Infection
SN - 0163-4453
IS - 2
ER -
ID: 160055710